Revolution Medicines raises ~$2.15B via equity and convertible note offerings

Revolution Medicines, Inc.

Equity offering: 10,563,381 shares at $142/sh + full over-allotment of 1,584,506 shares; net proceeds ~$1.65B.
Convertible note offering: $500M aggregate principal of 0.50% Convertible Senior Notes due 2033.
Equity closed April 16; note offering expected to close April 17; underwriters J.P. Morgan, TD Securities, Guggenheim.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.